117 related articles for article (PubMed ID: 15919504)
1. Severe hearing loss after liver transplantation.
Rifai K; Bahr MJ; Cantz T; Klempnauer J; Manns MP; Strassburg CP
Transplant Proc; 2005 May; 37(4):1918-9. PubMed ID: 15919504
[TBL] [Abstract][Full Text] [Related]
2. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.
Rifai K; Kirchner GI; Bahr MJ; Cantz T; Rosenau J; Nashan B; Klempnauer JL; Manns MP; Strassburg CP
Liver Transpl; 2006 Mar; 12(3):411-5. PubMed ID: 16456830
[TBL] [Abstract][Full Text] [Related]
3. High rate of unperceived hearing loss in patients after liver transplantation.
Rifai K; Pischke S; Agne C; Rosenau J; Klempnauer JL; Manns MP
Clin Transplant; 2012; 26(4):577-80. PubMed ID: 22280451
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
5. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
6. Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation.
Campbell MS; Rai J; Kozin E; Bloom RD; Markmann JF; Olthoff KM; Shaked A; Rajender Reddy K
Clin Transplant; 2007; 21(3):377-84. PubMed ID: 17488388
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
[TBL] [Abstract][Full Text] [Related]
9. Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation.
López Lago AM; Fernández Villanueva J; García Acuña JM; Paz ES; Vizoso EF; Pérez EV
Transplant Proc; 2007 Sep; 39(7):2318-9. PubMed ID: 17889176
[TBL] [Abstract][Full Text] [Related]
10. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
Neuberger J; Gunson B; Hubscher S; Nightingale P
Liver Transpl; 2004 Apr; 10(4):488-91. PubMed ID: 15048790
[TBL] [Abstract][Full Text] [Related]
15. Sudden hearing loss associated with tacrolimus in a liver transplant recipient.
Norman K; Bonatti H; Dickson RC; Aranda-Michel J
Transpl Int; 2006 Jul; 19(7):601-3. PubMed ID: 16764642
[No Abstract] [Full Text] [Related]
16. Impact of renal failure on liver transplantation survival.
Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
19. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus-related neurologic and renal complications in liver transplantation: A single-center experience.
Emiroglu R; Ayvaz I; Moray G; Karakayali H; Haberal M
Transplant Proc; 2006 Mar; 38(2):619-21. PubMed ID: 16549190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
